| 000 | 01357 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513200537.0 | ||
| 264 | 0 | _c19991223 | |
| 008 | 199912s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchlom, J | |
| 245 | 0 | 0 |
_aStrategies in the development of recombinant vaccines for colon cancer. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cDec 1999 |
||
| 300 |
_a672-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdjuvants, Immunologic |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntigen Presentation |
| 650 | 0 | 4 | _aAntigens, Neoplasm |
| 650 | 0 | 4 | _aCancer Vaccines |
| 650 | 0 | 4 | _aCarcinoembryonic Antigen |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xgenetics |
| 650 | 0 | 4 | _aCytokines |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aEpitopes |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aGenes, ras |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 | _aT-Lymphocytes |
| 700 | 1 | _aTsang, K Y | |
| 700 | 1 | _aKantor, J A | |
| 700 | 1 | _aAbrams, S I | |
| 700 | 1 | _aZaremba, S | |
| 700 | 1 | _aGreiner, J | |
| 700 | 1 | _aHodge, J W | |
| 773 | 0 |
_tSeminars in oncology _gvol. 26 _gno. 6 _gp. 672-82 |
|
| 999 |
_c10562271 _d10562271 |
||